Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD
- 1 June 1994
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 45 (6) , 1710-1721
- https://doi.org/10.1038/ki.1994.223
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Heterogeneous response to calcium by individual parathyroid cells.Journal of Clinical Investigation, 1993
- Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patientsKidney International, 1992
- The ‘Oral 1,25-Dihydroxyvitamin D3 Pulse Therapy’ in Hemodialysis Patients with Severe Secondary HyperparathyroidismNephron, 1991
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.Journal of Clinical Investigation, 1989
- Pharmacological Parathyroidectomy by Oral 1,25(OH)2D3 Pulse TherapyNephron, 1989
- Parathyroid hormone and 1,25(OH)2D3 in chronic renal failureKidney International, 1988
- Parenteral calcitriol for treatment of severe renal osteodystrophy in children with chronic renal insufficiencyThe Journal of Pediatrics, 1987
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984
- Parathyroid function in persistent hyperparathyroidism: Relationship to gland sizeKidney International, 1982